• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    The White House's last-minute compromise on drug copyright protections in the Trans-Pacific Partnership appears to have pleased nobody. (AP Photo)
    Healthcare

    Why everybody hates the drug deal in the trade pact

    Robert King -
    October 6, 2015 4:01 am
    0
    Nationwide there are nearly 2 million people living with hepatitis B and 3.2 million who have hepatitis C. (AP Photo/Paul Sakuma)
    Healthcare

    Health insurers accused of discrimination

    Robert King -
    October 5, 2015 6:19 pm
    0
    All of the bills to lower costs were filed earlier this year, but so far none has advanced out of their respective legislative committees. (AP Photo/Kelley McCall)
    Healthcare

    States try to rein in pricey drugs

    Robert King -
    October 3, 2015 10:28 am
    0
    Called the Improving Regulatory Transparency for New Medical Therapies Act, the bipartisan bill from Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., was approved unanimously by the Health, Education, Labor and Pensions Committee and next goes before the full Senate. (AP Photo/Toby Talbot, File)
    Healthcare

    Senate panel OKs drug competition bill

    Paige Winfield Cunningham -
    September 30, 2015 8:16 pm
    0
     Dems want information on sales, the cost of active pharmaceutical ingredients and how much Valeant spends on marketing. (AP Photo/Dado Galdieri)
    Healthcare

    Dems push for subpoena over drug price hike

    Robert King -
    September 28, 2015 6:41 pm
    0
    Clinton unveiled a plan this past week to combat rising prices, proposing reforms long championed by Democrats such as allowing Medicare the power to negotiate over drug prices. (AP)
    Campaigns

    Doubts emerge on Clinton drug price plan

    Robert King -
    September 26, 2015 4:01 am
    0
    With competition killed, drug prices are soaring
    Healthcare

    With competition killed, drug prices are soaring

    Robert King -
    September 24, 2015 4:01 am
    0
    Democrats have decried the skyrocketing prices of some medications and presidential candidates Hillary Clinton and Bernie Sanders have proposed new regulations on pharmaceutical companies intended to drive prices down. (AP file)
    Healthcare

    Drug lobby to name medical device exec as new CEO

    Paige Winfield Cunningham -
    September 23, 2015 4:20 pm
    0
    The price hike gained attention just as Americans have said in recent polls they were concerned about high drug prices. (AP file)
    Healthcare

    CEO relents on pricey pill

    Robert King -
    September 23, 2015 2:33 pm
    0
    Rep. Elijah Cummings wrote on Tuesday to the chairman of the House Oversight and Government Reform Committee about the drug Daparim. (AP Photo)
    Healthcare

    Dem slams ‘overnight’ drug price hike

    Robert King -
    September 22, 2015 7:29 pm
    0
    1...136137138...158Page 137 of 158
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.